Skip to Main Content Go to Sitemap
Innovation Showcase returns to highlight SickKids technologies and innovators
10 minute read

Innovation Showcase returns to highlight SickKids technologies and innovators


Annual commercialization event offers attendees access to emerging therapeutic and diagnostic SickKids technologies with high potential for market disruption and clinical impact.

The SickKids Innovation Showcase is returning for its second year, bringing together the latest in cutting-edge innovation at The Hospital for Sick Children (SickKids) with investors who can help advance ideas with the potential to improve health outcomes for patients. Hosted by the Industry Partnerships & Commercialization office at SickKids, the SickKids Innovation Showcase celebrates some of the most advanced health and life sciences ideas from the labs and clinics of SickKids innovators.

Attendees, primarily made up early-stage investors, venture capitalists, as well as pharmaceutical and biotechnology firms, get unparalleled access to emerging therapeutic and diagnostic technologies with high potential for market disruption and clinical impact.

Last year, over 200 people tuned into the virtual event to learn about the most advanced life science opportunities from SickKids, as well as to hear perspectives from top industry experts. This year, the event features seven of the top opportunities ripe for partnerships.

The virtual Innovation Showcase will be held on Tuesday, May 17. The Innovation Showcase includes pitch presentations from biopharmaceutical and medical technology research leads, followed by question-and-answer sessions and networking opportunities to meet SickKids innovators. Innovators will also have the chance to secure $10,000 in funding for their research, based on the audience’s vote for best presentation of the day.

SickKids Innovation Showcase.

Interested in attending?

Visit the IP&C website for registration details, and to learn more about how we work with external partners to advance SickKids research.


Check out the innovators and technologies that will be featured at the SickKids Innovation Showcase.


Xi Huang, Ph.D.

Senior Scientist, Developmental and Stem Cell Biology

Canada Research Chair in Cancer Biophysics


Treating primary brain cancer using an ion channel complex-targeting peptide

Novel Treatments for Cystic Fibrosis: Moving beyond CFTR modulators

Lisa Strug, Ph. D.

Senior Scientist, Genetics and Genome Biology Associate Director, The Centre for Applied Genomics

Headshot of Johanna Rommens

Johanna Rommens, PhD

Senior Scientist Emeritus, Genetics and Genome Biology

P. Lynne Howell, PhD

Senior Scientist, Molecular Medicine

Canada Research Chair in Structural Biology


Novel coatings and topical applications that prevent and eliminate bacterial and fungal biofilms


MATCH: Machine Learning-based robust assay to predict cardiotoxicity of pharmaceuticals 

Jason T. Maynes

Chief, Anesthesia and Pain Medicine Curtis Joseph and Harold Groves Chair in Anesthesia and Pain Medicine Associate Chief of Perioperative Services Research Scientist, Molecular Medicine

Headshot of Yu Sun

Yu Sun

Professor, Canada Research Chair in Micro and Nano Engineering Systems, Director, University of Toronto Robotics Institute

Headshot of Adam Schlien.

Adam Shlien, PhD, FCCMG

Senior Scientist, Genetics and Genome Biology

Canada Research Chair in Childhood Cancer Genomics


ML-based RNA analysis for cancer diagnosis, prognosis, and therapy guidance applications

Cynthia Hawkins, MD, PhD, FRCPC

Neuropathologist, Paediatric Laboratory Medicine

Senior Scientist, Cell Biology


Clinical development of liquid biopsy tools for cancer detection and monitoring

AtriumDB: Integrated AI/ML-based platform to store, recapitulate and interrogate waveform data


Headshot of Mjaye Mazwi.

Mjaye Mazwi, MBChB, MD

Co-Chair, Artificial Intelligence Medicine for Kids Staff Physician, Cardiology Project Investigator, Translational Medicine

Headshot of Robert Greer.

Robert Greer, B.Eng, M.Sc

Program Manager, Critical Care Medicine Technical Lead, Artificial Intelligence in Medicine (AIM)

Andrew Goodwin, B.Eng, PhD(C)

Research Collaborator, Critical Care Medicine


To provide real-world investor perspective, the event features several experts from top life sciences investment firms across North America.


Headshot of Vyas Ramanan

Vyas Ramanan, PhD

Principal, Third Rock Ventures

Headshot of Ann Schlesinger

Ann Schlesinger, PhD

Director, External Science & Partnering at Novartis Institutes for BioMedical Research, Novartis Institutes for Biomedical Research

Headshot of Vineeta Agarwala

Vineeta Agarwala, MD, PhD

General Partner, Andreesen Horowitz



Headshot of James Hardiman

James Hardiman, MBA

Partner, Data Collective (DCVC)

Headshot of Shobha Parthasarathi

Shobha Parthasarathi, PhD

VP, External Innovation and New Ventures, Xontogeny

Headshot of Andres Tellez

Andres Tellez, PhD

Sr. Director, NewCo Development, Johnson & Johnson Innovation - JJDC

Back to Top